Forus at a glance
As of- [1] Latest valuation: Bloomberg, September 8, 2026
- [2] Equity raised: Sum of the 1 sourced equity round in the funding history below (debt, tender offers and rumored rounds excluded), September 8, 2026
- [3] Lead investors: Bloomberg, September 8, 2026
What Forus does
Forus runs an AI platform that connects doctors, pharmacies, payers and drug makers to get patients from a prescription to their first dose.[1] Each prescription gets an AI agent, embedded in provider workflows, that handles insurance, financial assistance and supply chain steps; the service is free for providers and patients.[1] Sahir Jaggi founded the company in 2023, and it was formerly known as Tandem.[2],[3] The company says providers in all 50 states use the platform, treating patients in 85% of U.S. residential ZIP codes.[1] Jaggi told AlleyWatch that nine of the top 15 global biopharma companies use Forus data on where patients drop off.[4] Jaggi said Forus was not looking to raise and that Bain Capital Ventures approached it with an offer to lead.[4] Forus said it will use the money to expand to all specialties and care settings, extend what its AI agents do and hire.[1]
Leadership
- Forus is based in New York, and Jaggi is CEO.[1]
Is this your company? Get featured or correct your listing →
Company Snapshot
Forus is a Enterprise SaaS company.
Recent changes
- Sep 8, 2026Sep 8, 2026Raised $150M Series C at a $3B valuation Bloomberg
- Sep 8, 2026Sep 8, 2026First reported total funding: >$300M Bloomberg
- Sep 8, 2026Sep 8, 2026New investor: General Catalyst Bloomberg
- Sep 8, 2026Sep 8, 2026New investor: Accel Bloomberg
- Sep 8, 2026Sep 8, 2026New investor: Pear VC Bloomberg
Earlier changes (10)
- Sep 8, 2026Sep 8, 2026New investor: Vast Ventures Bloomberg
- Sep 8, 2026Sep 8, 2026New investor: Bain Capital Ventures Bloomberg
- Sep 8, 2026Sep 8, 2026New investor: Redpoint Ventures Bloomberg
- Sep 8, 2026Sep 8, 2026New investor: SV Angel Bloomberg
- Sep 8, 2026Sep 8, 2026New investor: BoxGroup Bloomberg
- Sep 8, 2026Sep 8, 2026New investor: Thrive Capital Bloomberg
- Sep 8, 2026Sep 8, 2026Forus Triples Valuation To $3B In Series C Pulse story
- Sep 8, 2026Sep 8, 2026Forus Triples to a $3B Value in Four Months Pulse story
- Sep 8, 2026Sep 8, 2026Valuation rose from $1B to $3B Bloomberg
- May 2026May 2026First reported valuation: ~$1B Bloomberg
Funding history
1 equity event · newest first · sources dated per row| Date | Round | Amount | Valuation | Lead investors | Source |
|---|---|---|---|---|---|
| Sep 8, 2026 | Series C | $150M | $3Bpost-money | Bloomberg |
Equity only. “Equity raised” above sums the rounds with a dated, linked source; rumored rounds, tender offers and secondary sales are listed but not counted, and debt financing is listed separately.
How Forus has been funded
In May 2026 Forus announced a Series B at a $1 billion valuation, with backers including Thrive Capital, General Catalyst, Accel, Bain Capital Ventures, Redpoint, BoxGroup and Pear VC.[3],[4],[1] On September 8, 2026, it announced a $150 million Series C at a $3 billion valuation, tripling its valuation and bringing total funding to more than $300 million.[1]
Investors and their roles
- Bain Capital Ventures, an investor since the seed round, led the Series C, and every existing institutional investor reinvested.[1]
Investors
Latest Pulse
- Sep 8, 2026Forus Triples Valuation To $3B In Series CForus raised a $150 million Series C led by Bain Capital Ventures at a $3 billion valuation, tripling its worth months after its Series B, as its AI agents automate prescription prior authorization for providers nationwide.→
- Sep 8, 2026Forus Triples to a $3B Value in Four MonthsForus, an AI network that automates prescription access between doctors, pharmacies and payers, raised $150 million at a $3 billion valuation -- roughly triple its mark from four months ago.→
Coverage Timeline
newest firstAll Coverage
FUNDING$150M Series C
Forus Triples Valuation To $3B In Series C
Forus raised a $150 million Series C led by Bain Capital Ventures at a $3 billion valuation, tripling its worth months after its Series B, as its AI agents automate prescription prior authorization for providers nationwide.
DEEP DIVE
Forus Triples to a $3B Value in Four Months
FUNDING$150M Series C
Forus Triples to a $3B Value in Four Months
Forus, an AI network that automates prescription access between doctors, pharmacies and payers, raised $150 million at a $3 billion valuation -- roughly triple its mark from four months ago.
DEEP DIVE
Value Add Research
Related Companies
Forus FAQ
What is Forus's valuation?
In May 2026 Forus announced a Series B at a $1 billion valuation, with backers including Thrive Capital, General Catalyst, Accel, Bain Capital Ventures, Redpoint, BoxGroup and Pear VC.[3],[4],[1]
How much has Forus raised?
On September 8, 2026, it announced a $150 million Series C at a $3 billion valuation, tripling its valuation and bringing total funding to more than $300 million.[1]
Who is the CEO of Forus?
Forus is based in New York, and Jaggi is CEO.[1]
What does Forus do?
Forus runs an AI platform that connects doctors, pharmacies, payers and drug makers to get patients from a prescription to their first dose.[1]
Who invested in Forus?
Lead investors in Forus's sourced funding rounds include Bain Capital Ventures. Per round: its September 2026 Series C was led by Bain Capital Ventures.
References
researched 2026-10-23Sources & methodologyshow
Where these figures come from
- Bloombergmajor outlet3 facts
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.